Marco Banini

Integration of radiation therapy with systemic treatments in head and neck cancer: expert opinion and roadmap to consensus

Carlotta Becherini, Marco Banini, Pierre Blanchard, Irene Braña et autres

it, fr, ps, es, sg, dk, ca, cn, be, de, gb (code pays fourni par la source)

EGFR-mutant NSCLC progressing on first-line osimertinib: rebiopsy in real-world and impact of second-line therapies (the “Rebiopsy on Osi” study)

Eleonora Gariazzo, Francesca Colamartini, Ornella Cantale, Andrea Mogavero et autres

BACKGROUND: Although rebiopsy at progression on osimertinib is recommended for patients with advanced EGFR-mutant non-small cell lung cancer (NSCLC), its real-world impact on clinical outcomes remains unclear. Rebiopsy on Osi is a multicenter, retrospective study assessing rebiopsy patterns, resistance mechanisms, and their …

it, us, br (code pays fourni par la source)

Sex-based differences in tolerability of developmental antibody-drug conjugates (ADCs) in non-small-cell lung cancer (NSCLC)

Claudia Parisi, Marco Banini, Francesco Mantuano, M. Aldea et autres

BACKGROUND: Sex-based differences in treatment-related adverse events (TRAEs) have been described across several anticancer therapies. However, sex-disaggregated safety data for antibody-drug conjugates (ADCs) in non-small-cell lung cancer (NSCLC) is lacking. PATIENTS AND METHODS: We conducted a monocentric cohort study including patients with …

fr, it, ch (code pays fourni par la source)

Sequencing Immunotherapy and Hypofractionated Radiotherapy in Frail Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma

Beatrice Bettazzi, Viola Salvestrini, Marco Banini, O. Ruggieri et autres

(1) Background: Hypofractionated radiotherapy and immunotherapy (IT) are possible treatment options for HNSCC patients unsuitable for standard curative treatment, yet no high-level evidence supports their combined use. We aim to report on the clinical outcome of a single-center cohort of HNSCC patients …

it (code pays fourni par la source)

NSCLC in Vulnerable and Special Populations: Toward Personalized Care

Claudia Parisi, Andrea De Giglio, Marco Banini, M. Tagliamento et autres

fr, it, my (code pays fourni par la source)

104P Toxicity patterns associated with sequencing immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs): A nationwide real-world analysis from the French Health Insurance Database (SNDS)

C. Parisi, Alexandre Lolivier, A. Rousseau, S. Foulon et autres

Sequencing tyrosine kinase inhibitors (TKIs) after immune checkpoint inhibitors (ICIs) has been associated with an increased risk of specific adverse events (AEs) in non-small cell lung cancer (NSCLC). However, comprehensive real-world data on both severe and chronic AEs are limited. Using the …

fr, it (code pays fourni par la source)

Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study

Paolo Bironzo, Alessandro Morabito, Sonia Silipigni, Vincenzo Adamo et autres

BACKGROUND: Stage III non-small cell lung cancer (NSCLC) includes a heterogeneous group of patients with diverse disease presentation, biological portrait, and prognosis. Optimal management requires tailored approaches and multimodal strategies through a multidisciplinary team (MDT) decision-making process. The BE-PACIFIC study primarily aimed …

it, us, gb (code pays fourni par la source)

Integrating Radiomics and Artificial Intelligence (AI) in Stereotactic Body Radiotherapy (SBRT)/Stereotactic Radiosurgery (SRS): Predictive Tools for Tailored Cancer Care

Ilaria Morelli, Marco Banini, Daniela Greto, Luca Visani et autres

Purpose: This systematic review aims to analyze the literature on the application of AI in predicting patient outcomes and treatment-related toxicity in those undergoing SBRT or SRS across heterogeneous tumor sites. Materials and methods: Our review conformed to the Preferred Reporting Items …

it (code pays fourni par la source)

Prediction Of Pathologic Tumor Response by MRI Restaging in Operable Soft Tissue Sarcoma following Preoperative Chemoradiotherapy

Daniela Greto, M. Loi, Giuliana Roselli, Annarita Palomba et autres

it (code pays fourni par la source)

2205 KRAS status in lung oligometastases treated with Stereotactic Body Radiotherapy (SBRT)

Mauro Loi, Marianna Valzano, Michele Aquilano, I. Morelli et autres

2077 Hepatic metastases SBRT: what can CECT features tell us about outcome prediction and follow up? A singlecenter retrospective study

Alessandro Biscarini, Linda Calistri, Maria Pisano, Gabriele Simontacchi et autres

2116 Stereotactic Body Radiotherapy (SBRT) for treatment of multiple liver metastases: dosimetric and clinical analysis

Ilaria Morelli, Mauro Loi, Michele Aquilano, Marianna Valzano et autres